Australia - English - Department of Health (Therapeutic Goods Administration)

hospira pty limited - cefazolin sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira pty limited - cefoxitin sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira pty limited - ceftriaxone sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride; mannitol - cancer chemotherapeutic drug - details of indications do not appear in the leaflet as exported from hospira australia

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection - excipient ingredients: sodium hydroxide; hydrochloric acid; sodium chloride; mannitol; water for injections - cancer chemotherapeutic drug - details of the indications do not appear on the leaflet as exported from hospira australia

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection - excipient ingredients: water for injections - indications for uk market - treatment of some types of lung cancer and ovarian cancer. indications for france market - it is recommended for the treatment of certain diseases of the ovaries, bronchi and aerodigestive pathways. indications for greece and cyprus market - carboplatin is a second-generation cisplatin derivative which has shown to possess antitumor activity against a number of malignancies. the drug is indicated for the treatment of the following solid tumours: ? ? advanced ovarian carcinoma of epithelial origin. ? ? small cell lung cancer. ? ? non-small cell lung cancer. ? ? epidermoid head and neck cancer. ? ? transitional cell cancer of the bladder (in combination with other cytostatic agents). ? ? cervical carcinoma in case of failure or unacceptable toxicity of cisplatin treatment or when the doctor considers that it cannot be tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection - excipient ingredients: water for injections; mannitol; sodium hydroxide; sulfuric acid - vincristine sulfate injection is indicated in acute leukemia. vincristine sulfate injection has also been shown to be useful in combination with other oncolytic agents in hodgkin's disease, non-hodgkin's malignant lymphomas (lymphocytic, mixed cell, histiocytic, undifferentiated, nodular and diffuse types), rhabdomyosarcoma, neuroblastoma, and wilm's tumor.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cytarabine,sodium chloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - carboplatin is indicated in the treatment of ovarian cancer of epithelial origin and in second line therapy after other treatments have failed.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - hyoscine hydrobromide -